EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications

Yuqing Niu, Li Wang, Yaoqing Zhang, Yanqiang Zou, Cheng Zhou

Frontiers in Cardiovascular Medicine · 04.08.2025 · 12

DOI: 10.3389/fcvm.2025.1629016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 04.08.2025. Verfasst von Yuqing Niu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis is an inflammatory form of programmed cell death, distinct from apoptosis, necroptosis, and ferroptosis, and is primarily mediated by gasdermin proteins and inflammatory caspases. Recent advances highlight the central role of pyroptosis in the pathogenesis and progression of a spectrum of cardiovascular diseases, including myocardial infarction, myocarditis, heart failure, atherosclerosis, hypertension, and cardiac arrhythmias. Activation of inflammasomes and the subsequent cleavage of gasdermins drive cell membrane pore formation, leading to the release of interleukin-1β (IL-1β), interleukin-18 (IL-18), and other pro-inflammatory mediators, amplifying tissue injury and sterile inflammation. Both experimental and clinical evidence reveal that targeting key molecules in the pyroptotic pathway, such as NLRP3 inflammasome, caspase-1, and gasdermin D, can attenuate myocardial injury, inhibit adverse cardiac remodeling, and stabilise atherosclerotic plaques. This review systematically summarises the current understanding of the molecular mechanisms of pyroptosis in cardiovascular pathology, details its disease-specific roles, and discusses translational and therapeutic perspectives. Modulating pyroptosis may provide new opportunities for the diagnosis, risk stratification, and treatment of cardiovascular diseases.

Schlagwörter

Stichwörter der Autor:innen

arrhythmiaatherosclerosiscardiovascular diseasesheart failurehypertensionmyocardial infarctionmyocarditispyroptosis

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Cardiovascular Surgery, Jingshan Union Hospital, Union Hospital, Huazhong University of Science and Technology, Jingshan, Hubei, China.
  • Department of Pharmacy, Qiaokou District People's Hospital, Wuhan, China.

Zitieren

APA

Niu, Y., Wang, L., Zhang, Y., Zou, Y., & Zhou, C. (2025). Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1629016

Vancouver

Niu Y, Wang L, Zhang Y, Zou Y, Zhou C. Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1629016

BibTeX
@article{Niu2025,
  author = {Niu, Yuqing and Wang, Li and Zhang, Yaoqing and Zou, Yanqiang and Zhou, Cheng},
  title = {Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fcvm.2025.1629016}
}
Kostenlos starten →